PLUS THERAPEUTICS, INC. — Director's Dealing 2014

Sep 4, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2014-09-02

Reporting Person: Girao Tiago (VP & Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-09-02	Incentive Stock Option (Right to Buy)	$1.36	A	150000	Acquired	2024-09-02	Common Stock (150000)	Direct

Footnotes

F1: The stock option will cliff vest 1/4th on the one year anniversary and vest 1/36th each month thereafter.